|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income, net | |||||
| Net loss | |||||
| Common Stock | |||||
| Total net loss | |||||
| Other comprehensive loss: | |||||
| Unrealized gain (loss) on marketable securities | |||||
| Total other comprehensive gain (loss) | |||||
| Total comprehensive loss | |||||
| Basic and diluted net loss per share | |||||
| Basic net loss per share | |||||
| Common Stock | |||||
| Preferred Stock | |||||
| Total basic net loss per share | |||||
| Diluted net loss per share | |||||
| Common Stock | |||||
| Preferred Stock | |||||
| Total diluted net loss per share | |||||
| Weighted-average shares used in computing basic and diluted net loss per share | |||||
| Weighted-average shares used in computing basic net loss per share | |||||
| Common Stock | |||||
| Preferred Stock | |||||
| Total weighted-average shares used in computing basic net loss per share | |||||
| Weighted-average shares used in computing diluted net loss per share | |||||
| Common Stock | |||||
| Preferred Stock | |||||
| Total weighted-average shares used in computing diluted net loss per share |
Loading...